Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • National Center for Advancing Translational Sciences
  • Bayer Diabetes Care
  • Pediatric Cancer Research Foundation
  • Rally Foundation